Page last updated: 2024-08-25

zoledronic acid and Brittle Bone Disease

zoledronic acid has been researched along with Brittle Bone Disease in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (12.50)	29.6817
2010's	22 (68.75)	24.3611
2020's	6 (18.75)	2.80

Authors

Authors	Studies
Biggin, A; Cheng, TL; Holman, AE; Lee, LR; Li, X; Little, DG; Munns, CF; O'Donohue, AK; Schindeler, A; Vasiljevski, ER	1
Hu, J; Jiang, Y; Li, M; Liu, J; Sun, L; Wang, O; Xia, W; Xing, X; Zhang, Q	1
Hafeez, S; Ibrahim, MN; Khoso, ZA; Laghari Br, TM; Raza, SJ; Riaz, M	1
Carsen, S; Feber, J; Khan, N; Konji, VN; Koujok, K; Molina, MO; Page, M; Rauch, F; Robinson, ME; Seale, E; Sheffield, H; Smit, K; Walker, S; Ward, LM	1
Hald, JD; Javaid, MK; Keerie, C; Lam, W; Langdahl, BL; Osborne, P; Ralston, SH; Walsh, J; Weir, CJ	1
Ekbote, V; Karguppikar, MB; Khadilkar, A; Khadilkar, V	1
Cheng, TL; Kneissel, M; Kramer, I; Little, DG; Mikulec, K; Munns, C; Peacock, L; Schindeler, A	1
Godinho, F; Santos, MJ; Sousa, S	1
Biggin, A; Munns, CF	1
Jiang, Y; Li, L; Liu, Y; Lv, F; Song, Y; Wang, O; Xia, W; Xing, X; Xu, X	1
Bellampalli, R; Didel, S; Kirpal, H; Miyanath, S; Mullapudi, N; Panigrahi, I; Rao, S	1
Bilodeau, C; Boitor, M; Carrier, JI; Ferland, CE; Le May, S; Ngheim, T; Rauch, F; Tsimicalis, A	1
Alhousseini, A; Berman, S; Bryant, D; Hernandez-Andrade, E; Jaiman, S; Mahaseth, M; Tan, S; Zeineddine, S	1
Jiang, Y; Li, LJ; Li, M; Wang, O; Xia, WB; Yu, W; Zhao, DC; Zheng, WB	1
Bennetts, BH; Biggin, A; Briody, JN; Munns, CF; Ormshaw, E; Wong, KK	1
Arponen, H; Haukka, J; Mäkitie, O; Valta, H; Vuorimies, I; Waltimo-Sirén, J	1
Biggin, A; Briody, JN; Coorey, CP; Munns, CF; Zheng, L	1
Anam, EA; Fassier, F; Glorieux, FH; Hamdy, R; Rauch, F	1
Fassier, F; Glorieux, FH; Montpetit, K; Ouellet, J; Palomo, T; Rauch, F; Sato, A	1
Aglan, MS; El Banna, RA; Elnashar, M; Ibrahim, MM; Otaify, GA; Temtamy, SA	1
George, S; Hummel, K; Kaplan, P; Levine, MA; Monk, HM; Weber, DR	1
Khandelwal, N; Kumar, C; Meena, BL; Panigrahi, I; Somasekhara Aradhya, A	1
Jiang, Y; Li, M; Liu, Y; Lv, F; Ma, DD; Wang, JY; Wang, O; Xia, WB; Xing, XP; Xu, XJ; Yu, W	1
Jiang, Y; Li, M; Liu, Y; Lv, F; Ma, DD; Song, LJ; Wang, JW; Wang, JY; Wang, O; Xia, WB; Xing, XP; Xu, XJ	1
Yamashita, S	2
Brown, JJ; Zacharin, MR	1
Das, RR; Marwaha, RK; Panigrahi, I	1
Das, RR; Khandelwal, N; Marwaha, RK; Panigrahi, I; Sharda, S	1
Hero, M; Mäkitie, O; Toiviainen-Salo, S; Vuorimies, I	1
Barros, ER; de Oliveira, TP; Lazaretti-Castro, M; Saraiva, GL	1
Briody, JN; Eisman, JA; Gardiner, EM; Little, DG; McEvoy, A; Smith, EJ; Smith, NC	1

Reviews

3 review(s) available for zoledronic acid and Brittle Bone Disease

Article	Year
Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta. Current osteoporosis reports, 2017, Volume: 15, Issue:5 Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Orthopedic Procedures; Osteogenesis Imperfecta; Pamidronate; Physical Therapy Modalities; Quality of Life; Zoledronic Acid	2017
[Bisphosphonates and other new therapeutic agents for the treatmednt of osteogenesis imperfecta]. Clinical calcium, 2009, Volume: 19, Issue:2 Topics: Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Child, Preschool; Clinical Trials as Topic; Denosumab; Diphosphonates; Drug Administration Schedule; Genetic Therapy; Humans; Imidazoles; Infusions, Intravenous; Osteogenesis Imperfecta; Pamidronate; RANK Ligand; Severity of Illness Index; Stem Cell Transplantation; Teriparatide; Zoledronic Acid	2009
[Bone and joint diseases in children. Bisphosphonates in osteogenesis imperfecta]. Clinical calcium, 2010, Volume: 20, Issue:6 Topics: Administration, Oral; Alendronate; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Humans; Imidazoles; Infant; Infusions, Intravenous; Osteogenesis Imperfecta; Pamidronate; Severity of Illness Index; Zoledronic Acid	2010

Trials

10 trial(s) available for zoledronic acid and Brittle Bone Disease

Article	Year
Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta. BMJ open, 2023, 11-22, Volume: 13, Issue:11 Topics: Adolescent; Adult; Bone Density; Bone Density Conservation Agents; Fractures, Bone; Humans; Osteogenesis Imperfecta; Pain; Quality of Life; Randomized Controlled Trials as Topic; Teriparatide; Zoledronic Acid	2023
ZOLEDRONIC ACID VERSUS ALENDRONATE IN THE TREATMENT OF CHILDREN WITH OSTEOGENESIS IMPERFECTA: A 2-YEAR CLINICAL STUDY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2018, Volume: 24, Issue:2 Topics: Adolescent; Alendronate; Bone Density; Child; Child, Preschool; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; Humans; Imidazoles; Incidence; Male; Osteogenesis Imperfecta; Time Factors; Treatment Outcome; Zoledronic Acid	2018
Effects of zoledronic acid on vertebral shape of children and adolescents with osteogenesis imperfecta. Bone, 2019, Volume: 127 Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Humans; Longitudinal Studies; Osteogenesis Imperfecta; Spine; Zoledronic Acid	2019
Fracture during intravenous bisphosphonate treatment in a child with osteogenesis imperfecta: an argument for a more frequent, low-dose treatment regimen. Hormone research in paediatrics, 2014, Volume: 81, Issue:3 Topics: Bone Density; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Humans; Imidazoles; Osteogenesis Imperfecta; Radius Fractures; Tomography, X-Ray Computed; Zoledronic Acid	2014
The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta. Hormone research in paediatrics, 2015, Volume: 83, Issue:3 Topics: Administration, Intravenous; Bone Density; Child; Child, Preschool; Diphosphonates; Drug Substitution; Female; Humans; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Pamidronate; Radiography; Spine; Zoledronic Acid	2015
THE CLINICAL CHARACTERISTICS AND EFFICACY OF BISPHOSPHONATES IN AUDLT PATIENTS WITH OSTEOGENESIS IMPERGECTA. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2016, Volume: 22, Issue:11 Topics: Absorptiometry, Photon; Adolescent; Adult; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Osteogenesis Imperfecta; Outcome Assessment, Health Care; Young Adult; Zoledronic Acid	2016
Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis. Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:1 Topics: Adolescent; Bone Density; Bone Density Conservation Agents; Child; Child Development; Child, Preschool; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; Humans; Imidazoles; Injections, Intravenous; Kidney; Liver; Male; Osteogenesis Imperfecta; Osteoporosis; Pamidronate; Treatment Outcome; Zoledronic Acid	2009
Response to zolendronic acid in children with type III osteogenesis imperfecta. Journal of bone and mineral metabolism, 2010, Volume: 28, Issue:4 Topics: Bone Density Conservation Agents; Child, Preschool; Diphosphonates; Female; Humans; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Radiography; Zoledronic Acid	2010
Zoledronic acid treatment in children with osteogenesis imperfecta. Hormone research in paediatrics, 2011, Volume: 75, Issue:5 Topics: Adolescent; Bone Density; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; Humans; Imidazoles; Infant; Lumbar Vertebrae; Male; Osteogenesis Imperfecta; Spinal Fractures; Treatment Outcome; Zoledronic Acid	2011
Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta. Journal of pediatric endocrinology & metabolism : JPEM, 2012, Volume: 25, Issue:5-6 Topics: Adolescent; Bone Density; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Pamidronate; Prospective Studies; Treatment Outcome; Zoledronic Acid	2012

Other Studies

19 other study(ies) available for zoledronic acid and Brittle Bone Disease

Article	Year
Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta. Bone, 2022, Volume: 159 Topics: Animals; Bone and Bones; Bone Density; Disease Models, Animal; Growth Hormone; Human Growth Hormone; Mice; Osteogenesis Imperfecta; Zoledronic Acid	2022
Relationship of Pathogenic Mutations and Responses to Zoledronic Acid in a Cohort of Osteogenesis Imperfecta Children. The Journal of clinical endocrinology and metabolism, 2022, 08-18, Volume: 107, Issue:9 Topics: Bone Density; Bone Density Conservation Agents; Child; Collagen Type I; Diphosphonates; Humans; Mutation; Osteogenesis Imperfecta; Zoledronic Acid	2022
Safety and Efficacy of Zoledronic Acid in children with Osteogenesis Imperfecta. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022, Volume: 32, Issue:9 Topics: Bone Density Conservation Agents; Child; Diphosphonates; Female; Fractures, Bone; Humans; Male; Osteogenesis Imperfecta; Treatment Outcome; Zoledronic Acid	2022
Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI. Calcified tissue international, 2023, Volume: 112, Issue:5 Topics: Bone Density; Bone Density Conservation Agents; Calcium; Child; Denosumab; Humans; Hypercalcemia; Male; Osteogenesis Imperfecta; Zoledronic Acid	2023
Comprehensive evaluation of bone health using DXA and pQCT in an Indian boy with osteogenesis imperfecta. BMJ case reports, 2020, Dec-13, Volume: 13, Issue:12 Topics: Absorptiometry, Photon; Bone Density; Bone Density Conservation Agents; Calcium; Child; Diphosphonates; Fractures, Bone; Humans; Male; Osteogenesis Imperfecta; Tomography, X-Ray Computed; Vitamin D; Zoledronic Acid	2020
Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta. Bone, 2017, Volume: 101 Topics: Adaptor Proteins, Signal Transducing; Animals; Antibodies; Bone Density; Diphosphonates; Disease Models, Animal; Female; Glycoproteins; Imidazoles; Intercellular Signaling Peptides and Proteins; Mice; Osteogenesis; Osteogenesis Imperfecta; Zoledronic Acid	2017
Letter to the Editor: Therapies for Osteogenesis Imperfecta. Acta medica portuguesa, 2017, 02-27, Volume: 30, Issue:2 Topics: Bone Density Conservation Agents; Child, Preschool; Diphosphonates; Humans; Imidazoles; Male; Osteogenesis Imperfecta; Zoledronic Acid	2017
Novel mutation in a family with WNT1-related osteoporosis. European journal of medical genetics, 2018, Volume: 61, Issue:7 Topics: Bone Density Conservation Agents; Diphosphonates; Fractures, Bone; Genetic Variation; Humans; Imidazoles; Infant; Male; Mutation; Osteogenesis Imperfecta; Wnt1 Protein; Zoledronic Acid	2018
Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle. European journal of pediatrics, 2018, Volume: 177, Issue:6 Topics: Adolescent; Bone Density Conservation Agents; Child; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Musculoskeletal Pain; Osteogenesis Imperfecta; Pain Measurement; Pain Perception; Parents; Pilot Projects; Prospective Studies; Quality of Life; Self Report; Treatment Outcome; Young Adult; Zoledronic Acid	2018
A Non-Lethal Osteogenesis Imperfecta Type II Mutation. Gynecologic and obstetric investigation, 2019, Volume: 84, Issue:2 Topics: Adult; Collagen Type I; Collagen Type I, alpha 1 Chain; Female; Humans; Infant; Infant, Newborn; Mutation; Osteogenesis Imperfecta; Pregnancy; Pregnancy Outcome; Ultrasonography, Prenatal; Zoledronic Acid	2019
Cranial base pathology in pediatric osteogenesis imperfecta patients treated with bisphosphonates. Journal of neurosurgery. Pediatrics, 2015, Volume: 15, Issue:3 Topics: Adolescent; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Drug Administration Schedule; Etidronic Acid; Female; Follow-Up Studies; Humans; Imidazoles; Infant; Kaplan-Meier Estimate; Logistic Models; Male; Osteogenesis Imperfecta; Pamidronate; Platybasia; Retrospective Studies; Risedronic Acid; Skull Base; Zoledronic Acid	2015
Osteotomy Healing in Children With Osteogenesis Imperfecta Receiving Bisphosphonate Treatment. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2015, Volume: 30, Issue:8 Topics: Adolescent; Adult; Bone Regeneration; Child; Child, Preschool; Diphosphonates; Female; Humans; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Osteotomy; Radiography; Retrospective Studies; Zoledronic Acid	2015
Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2015, Volume: 30, Issue:12 Topics: Absorptiometry, Photon; Adolescent; Anthropometry; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcium; Child; Child, Preschool; Collagen Type I; Collagen Type I, alpha 1 Chain; Densitometry; Diphosphonates; Female; Femoral Fractures; Follow-Up Studies; Fractures, Compression; Humans; Imidazoles; Infant; Infusions, Intravenous; Lumbar Vertebrae; Male; Mutation; Osteogenesis Imperfecta; Pamidronate; Scoliosis; Spinal Fusion; Tibial Fractures; Zoledronic Acid	2015
Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, Volume: 27, Issue:1 Topics: Adolescent; Bone Density; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Drug Administration Schedule; Female; Fractures, Bone; Humans; Imidazoles; Infant; Infusions, Intravenous; Male; Osteogenesis Imperfecta; Pain Measurement; Prospective Studies; Severity of Illness Index; Zoledronic Acid	2016
Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:11 Topics: Acute-Phase Reaction; Adolescent; Alkaline Phosphatase; Bone Density Conservation Agents; Bone Diseases; Calcitriol; Calcium; Child; Child, Preschool; Diphosphonates; Female; Humans; Hypercalcemia; Hypocalcemia; Hypophosphatemia; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Osteoporosis; Prospective Studies; Retrospective Studies; Risk Factors; Young Adult; Zoledronic Acid	2015
Zoledronate for Osteogenesis imperfecta: evaluation of safety profile in children. Journal of pediatric endocrinology & metabolism : JPEM, 2016, Aug-01, Volume: 29, Issue:8 Topics: Bone Density; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; Humans; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Prognosis; Retrospective Studies; Safety; Zoledronic Acid	2016
Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid. Journal of human genetics, 2017, Volume: 62, Issue:2 Topics: Adult; Asian People; Base Sequence; Bone Density; Bone Density Conservation Agents; Bone Resorption; Child; Child, Preschool; China; Collagen Type I; Collagen Type I, alpha 1 Chain; Diphosphonates; Female; Fractures, Bone; High-Throughput Nucleotide Sequencing; Humans; Imidazoles; Male; Membrane Proteins; Osteogenesis Imperfecta; Sequence Analysis, DNA; Tacrolimus Binding Proteins; Young Adult; Zoledronic Acid	2017
Zolendronate in osteogenesis imperfecta. Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:8 Topics: Bone Density; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Fractures, Spontaneous; Humans; Imidazoles; Infant; Infant, Newborn; Lumbar Vertebrae; Male; Osteogenesis Imperfecta; Radiography; Retrospective Studies; Treatment Outcome; Zoledronic Acid	2009
Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:10 Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Cartilage; Child; Child, Preschool; Diaphyses; Diphosphonates; Humans; Imidazoles; Osteogenesis Imperfecta; Osteoporosis; Rabbits; Tibia; Time Factors; Zoledronic Acid	2005